Literature DB >> 10752014

Extreme thrombocytosis in response to PEG-ADA: early therapeutic and risk indicator.

V R Marwaha1, D H Italia, F Esper, R W Hostoffer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752014     DOI: 10.1177/000992280003900309

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  2 in total

1.  Increasing importance of stem cell gene therapy in adenosine deaminase deficiency?

Authors:  Oner Ozdemir
Journal:  Clin Vaccine Immunol       Date:  2006-03

2.  Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID).

Authors:  Claire Booth; H Bobby Gaspar
Journal:  Biologics       Date:  2009-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.